Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 1865Lung Neoplasms 1300Small Cell Lung Carcinoma 327Colorectal Neoplasms 275Breast Neoplasms 244Melanoma 222Neoplasms 214Ovarian Neoplasms 192Neoplasm Metastasis 184Pancreatic Neoplasms 155Squamous Cell Carcinoma of Head and Neck 150Stomach Neoplasms 141Head and Neck Neoplasms 122Carcinoma, Renal Cell 120Triple Negative Breast Neoplasms 109Prostatic Neoplasms 107Esophageal Neoplasms 107Endometrial Neoplasms 98Uterine Cervical Neoplasms 96Urinary Bladder Neoplasms 88Colonic Neoplasms 87Mesothelioma 86Mesothelioma, Malignant 80Carcinoma, Hepatocellular 75Brain Neoplasms 71Sarcoma 63Disease 62Adenocarcinoma of Lung 60Carcinoma, Transitional Cell 54Gastrointestinal Neoplasms 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced NSCLC × Thoracic × 1 year × Clear all
NCT06924606 2026-02-06

Evaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy and Immunotherapy

Shanghai Junshi Bioscience Co., Ltd.

Phase 2 Recruiting
66 enrolled
Thoracic

Advanced NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡